Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1381-2024Class II

Medivance Neonatal ArcticGel Pads, REF: 31802, 3180202, 31802C

Medivance Inc. / initiated 2024-02-16 / Open, Classified / root cause: manufacturing process

Medivance Inc. began a recall of Medivance Neonatal ArcticGel Pads, REF: 31802, 3180202, 31802C on . FDA classified it as Class II and gives the reason as "Neonatal pads are experiencing reduced water flow, which may reduce or prevent water heating or cooling performance of the pads that are part of a temperature management system". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1381-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Medivance Inc.
Product
Medivance Neonatal ArcticGel Pads, REF: 31802, 3180202, 31802C
Product code
DWJ System, Thermal Regulating
Reason for recall
Neonatal pads are experiencing reduced water flow, which may reduce or prevent water heating or cooling performance of the pads that are part of a temperature management system.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On 2/16/24, BD mailed or emailed recall notices to customers who were asked to do the following: 1) Immediately Discontinue Use 2) Immediately quarantine affected pads, record your inventory totals on the Customer Response Form, discard all devices within your facility's control per your facility's procedures. 3) Share this notice with any users of the product within your facilities or with any facility affected product was distributed to. 4) Complete and return the attached Customer Response Form to the BD contact noted on the form. If you require further assistance contact BD Customer Support at 1-844-823-5433. Say "Recall" when prompted M-F 8am -5pm CT.
Quantity in commerce
1,654
Distribution
Worldwide - US Nationwide distribution including in the states of IL, AL, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Belgium, Australia, Singapore, South Korea, Taiwan, Japan, China, Thailand.
Product codes and lots
REF/UDI-DI/Lot(Expiration Date): 31802/00801741132131/NGGX5390(31Oct2024), NGGX1179(31Oct2024), NGGX1156(31Oct2024), NGHP2415(28Feb2025), NGHP2411(28Feb2025), NGHT1139(31May2025), NGHTY603(31May2025), NGHV4383(31Jul2025), NGHW1507(31Aug2025); 3180202/10801741132138/NGGZ2622(31Dec2024), NGGV1829(31Aug2024), NGGW3254(30Sep2024), NGHQ2940(31Mar2025); 31802C/00801741223457/NGGV1784(31Aug2024)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1381-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1381-2024Class IIOngoingVoluntary: Firm initiated